Hi Sarah

Thank you for your email regarding the wholesale cost to PHARMAC or N per year of Effexor XR and number of people funded, versus the wholesale cost to PHARMAC or NZ for Enlafax and the number of people funded.

This email is to acknowledge that your request for information will be treated as such under the Official Information Act (1982). Your request is currently being worked on and we will have a reply to you as soon as possible and no later than the due date of 7 June 2018.

Kind regards
Katie
PHARMAC

-----Original Message-----
From: Sarah Bellamy [mailto:[FOI #7786 email]]
Sent: Wednesday, May 9, 2018 12:35 AM
To: Web Enquiry <[email address]>
Subject: [SPAM]? Official Information request - Cost of Effexor v's Enlafax

Dear Pharmaceutical Management Agency,

I am writing to request the wholesale cost to pharmac or NZ per year of Effexor XR and number of people funded.
V's
The wholesale cost to pharmac or NZ of Enlafax and rhe number of people funded.

Yours faithfully,
Sarah

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #7786 email]

Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

**********************************************************************
This email and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. If you have received this email in error please notify
the system manager.

This footnote also confirms that this email message has been swept by
MIMEsweeper for the presence of computer viruses.

www.clearswift.com
**********************************************************************

hide quoted sections

Hi Sarah

Thank you for your email regarding the wholesale cost to PHARMAC or NZ per year of Effexor XR and number of people funded, versus the wholesale cost to PHARMAC or NZ for Enlafax and the number of people funded.

Below is a link to a notification regarding the decision to award sole supply of venlafaxine that was published on our website.
https://www.pharmac.govt.nz/news/notific...

This notification contains the following information:
• Price and subsidy for Enlafax (which is currently funded)
• Price and subsidy for Arrow-Venlafaxine XR and Efexor XR (which are no longer funded).

You can also find information about the number of people on venlafaxine in our Year in Review 2017 document. I have copied the link below for your convenience.
https://www.pharmac.govt.nz/about/2017/m...

Is this information sufficient? If not, we will need clarification to support your request, specifically the timeframe of information you are seeking (ie what years are you referring to).

Can you please respond to acknowledge you have received this email, and whether this information is sufficient or not.

Kind regards
Katie
PHARMAC

-----Original Message-----
From: Sarah Bellamy [mailto:[FOI #7786 email]]
Sent: Wednesday, May 9, 2018 12:35 AM
To: Web Enquiry <[email address]>
Subject: [SPAM]? Official Information request - Cost of Effexor v's Enlafax

Dear Pharmaceutical Management Agency,

I am writing to request the wholesale cost to pharmac or NZ per year of Effexor XR and number of people funded.
V's
The wholesale cost to pharmac or NZ of Enlafax and rhe number of people funded.

Yours faithfully,
Sarah

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #7786 email]

Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

**********************************************************************
This email and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. If you have received this email in error please notify
the system manager.

This footnote also confirms that this email message has been swept by
MIMEsweeper for the presence of computer viruses.

www.clearswift.com
**********************************************************************

hide quoted sections

Hi Sarah

As stated in my previous response, you can find information about the number of people on venlafaxine in our Year in Review 2017 document: https://www.pharmac.govt.nz/about/2017/m...

There are approximately 45,000 people taking venlafaxine.

I'm not quite sure if this is the information you are after, it may be easier for you to call so I can better understand what information you are seeking. You can reach me at 0800 660 050.

Kind regards
Katie
PHARMAC

-----Original Message-----
From: Sarah Bellamy [mailto:[FOI #7786 email]]
Sent: Friday, May 11, 2018 12:15 PM
To: Web Enquiry <[email address]>
Subject: RE: Official Information request - Cost of Effexor v's Enlafax

Dear Web Enquiry,

How many people are being funded now who are getting Enlafax.

Yours sincerely,

Sarah Bellamy

-----Original Message-----

Hi Sarah

Thank you for your email regarding the wholesale cost to PHARMAC or NZ per year of Effexor XR and number of people funded, versus the wholesale cost to PHARMAC or NZ for Enlafax and the number of people funded.

Below is a link to a notification regarding the decision to award sole supply of venlafaxine that was published on our website.
https://www.pharmac.govt.nz/news/notific...

This notification contains the following information:
• Price and subsidy for Enlafax (which is currently funded)
• Price and subsidy for Arrow-Venlafaxine XR and Efexor XR (which are no longer funded).

You can also find information about the number of people on venlafaxine in our Year in Review 2017 document. I have copied the link below for your convenience.
https://www.pharmac.govt.nz/about/2017/m...

Is this information sufficient? If not, we will need clarification to support your request, specifically the timeframe of information you are seeking (ie what years are you referring to).

Can you please respond to acknowledge you have received this email, and whether this information is sufficient or not.

Kind regards
Katie
PHARMAC

-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #7786 email]

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

**********************************************************************
This email and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. If you have received this email in error please notify
the system manager.

This footnote also confirms that this email message has been swept by
MIMEsweeper for the presence of computer viruses.

www.clearswift.com
**********************************************************************

hide quoted sections